<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Friedman, Allon</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Impact of Obesity, Hypertension, and Glycemia on CKD</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">22-23</style></pages><abstract><style  face="normal" font="default" size="100%">Obesity-related glomerulopathy (ORG) is distinct from idiopathic focal segmental glomerulosclerosis, and is an emerging epidemic clinical entity [Kambham N et al. Kidney Int 2001]. This article discusses evidence for a link between obesity and the development and progression of chronic kidney disease (CKD) and end-stage renal disease, athological patterns of injury relevant to ORG, an overview of glycemic control in patients with diabetic kidney disease, as well as a relationship among hypertension, diabetes, and CKD .</style></abstract><number><style face="normal" font="default" size="100%">11</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>